We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Device Developed for Rapid On-Site Pathogen Diagnostics

By Doris Mendieta, Contributing News Editor
Posted on 26 Oct 2014
Print article
Image: Prototype of the SP-IRIS (single particle - interferometric reflectance imaging sensor), which detects pathogens by shining light from multicolor LED sources on viral nanoparticles trapped onto the sensor surface by a coating of virus-specific antibodies (Photo courtesy of NexGen Arrays).
Image: Prototype of the SP-IRIS (single particle - interferometric reflectance imaging sensor), which detects pathogens by shining light from multicolor LED sources on viral nanoparticles trapped onto the sensor surface by a coating of virus-specific antibodies (Photo courtesy of NexGen Arrays).
A novel nanotechnology-based prototype device can detect pathogens such as Ebola and other hemorrhagic fever viruses – quickly and on-site.

The novel device is being developed by a research team led by Boston University's (Boston, MA, USA) Selim Ünlü, professor of biomedical engineering, and John Connor, professor of medical microbiology. Conventional fluorescent label-based virus detection methods require expensive lab equipment, significant sample preparation, transport and processing times, and extensive user training. A solution in pathogen diagnostics, and thereby also treatment and containment, may come from this device—a rapid, label-free, chip-scale photonic system that can provide affordable, simple, accurate on-site detection, also in resource-limited countries. A potentially game-changing technology, the device identifies individual viruses based on size variations resulting from distinct genome lengths and other factors.

The first demonstration of the concept, reported in 2010 and developed by a group led by Prof. Ünlü in collaboration with Bennett Goldberg, professor of physics at BU, showed the ability to pinpoint and size single H1N1 virus particles. Now, after 4 years of refining the instrumentation with the collaboration of Prof. Connor's group and researchers at the University of Texas Medical Branch, the team has demonstrated simultaneous detection of multiple viruses in blood serum samples—including viruses genetically modified to mimic the behavior of Ebolavirus and the Marburgvirus.

“Others have developed different label-free systems, but none have been nearly as successful in detecting nanoscale viral particles in complex media,” says Prof. Ünlü, referring to typical (e.g., unprocessed blood) samples that may have a mix of viruses, bacteria, and proteins. He added, “Leveraging expertise in optical biosensors and hemorrhagic fever diseases, our collaborative research effort has produced a highly sensitive device.” Also, the system requires little to no sample preparation time and delivers answers in about 1 hour. “By minimizing sample preparation and handling, our system can reduce potential exposure to health care workers,” said Prof. Connor, “And by looking for multiple viruses at the same time, patients can be diagnosed much more effectively.”

The shoebox-sized, battery-operated prototype – the single particle - interferometric reflectance imaging sensor (SP-IRIS) – detects by shining light from multicolor LED sources on viral nanoparticles trapped onto the sensor surface by a coating of virus-specific antibodies. Interference of light reflected from the surface is modified by the presence of the particles, producing a distinct signal that reveals the size and shape of each particle. The system is capable of high-throughput as the sensor surface is very large and can capture the telltale responses of up to a million nanoparticles.

In collaboration with BD Technologies (Research Triangle Park, NC, USA) and the start-up NexGen Arrays (Boston, MA, USA), the team is now working on making SP-IRIS more robust, field-ready, and fast — ideally delivering answers within 30 minutes—through further technology development and preclinical trials. SP-IRIS devices are now being tested in several labs, including a Biosafety Level-4 (BSL-4) lab at the University of Texas Medical Branch equipped to work with hemorrhagic viruses. Other tests will be conducted at BU’s NEIDL once the facility is BSL-4 approved. Based on the current rate of progress, the instrument could be ready to enter the field in 5 years.

The research, by Daaboul GG et al., appeared in the journal ACS Nano, May, 2014.

Related Links:

Boston University
BU National Emerging Infectious Diseases Laboratories (NEIDL) 
NexGen Arrays 


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.